CN114053296A - Eyesight improving nano gasified rubber for myopia and its prepn - Google Patents
Eyesight improving nano gasified rubber for myopia and its prepn Download PDFInfo
- Publication number
- CN114053296A CN114053296A CN202111427174.2A CN202111427174A CN114053296A CN 114053296 A CN114053296 A CN 114053296A CN 202111427174 A CN202111427174 A CN 202111427174A CN 114053296 A CN114053296 A CN 114053296A
- Authority
- CN
- China
- Prior art keywords
- parts
- eyesight
- myopia
- gasified
- nano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004438 eyesight Effects 0.000 title claims abstract description 94
- 208000001491 myopia Diseases 0.000 title claims abstract description 54
- 230000004379 myopia Effects 0.000 title claims abstract description 54
- 230000000694 effects Effects 0.000 claims abstract description 64
- 150000004676 glycans Chemical class 0.000 claims abstract description 25
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 25
- 239000005017 polysaccharide Substances 0.000 claims abstract description 25
- 239000003292 glue Substances 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 24
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 24
- 229920001661 Chitosan Polymers 0.000 claims description 24
- 229940116229 borneol Drugs 0.000 claims description 24
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 24
- 239000013078 crystal Substances 0.000 claims description 24
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 24
- SQMGCPHFHQGPIF-UUKFDUHUSA-N gns9eex31x Chemical compound O[C@@H]([C@]([C@H]([C@H](O)[C@]12O)OC)(O)C3)[C@H]2[C@@H]3[C@@]2([C@H](C[C@H]3O)OC)[C@H]4[C@@H]1[C@H](OC)[C@@H]2[C@]3(COC)CN4CC SQMGCPHFHQGPIF-UUKFDUHUSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 18
- 235000019991 rice wine Nutrition 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 4
- 239000003973 paint Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 210000001508 eye Anatomy 0.000 abstract description 41
- 239000003889 eye drop Substances 0.000 abstract description 22
- 208000030533 eye disease Diseases 0.000 abstract description 16
- 210000000744 eyelid Anatomy 0.000 abstract description 16
- 208000002177 Cataract Diseases 0.000 abstract description 14
- 210000005252 bulbus oculi Anatomy 0.000 abstract description 12
- 229940012356 eye drops Drugs 0.000 abstract description 9
- 238000002309 gasification Methods 0.000 abstract description 7
- 201000010041 presbyopia Diseases 0.000 abstract description 7
- 230000037303 wrinkles Effects 0.000 abstract description 6
- 230000004410 intraocular pressure Effects 0.000 abstract description 4
- 102000014824 Crystallins Human genes 0.000 abstract description 2
- 108010064003 Crystallins Proteins 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 210000000695 crystalline len Anatomy 0.000 description 18
- 239000011521 glass Substances 0.000 description 15
- 239000000843 powder Substances 0.000 description 14
- 239000003814 drug Substances 0.000 description 12
- 238000001035 drying Methods 0.000 description 12
- 239000006187 pill Substances 0.000 description 7
- 210000001525 retina Anatomy 0.000 description 6
- 239000008187 granular material Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 208000003464 asthenopia Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000000720 eyelash Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 3
- 206010013774 Dry eye Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 208000031973 Conjunctivitis infective Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 208000034699 Vitreous floaters Diseases 0.000 description 2
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000004240 ciliary body Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000036040 emmetropia Effects 0.000 description 2
- 239000003885 eye ointment Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 206010024214 Lenticular opacities Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 206010030348 Open-Angle Glaucoma Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000029091 Refraction disease Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 235000013559 Schnittsellerie Nutrition 0.000 description 1
- 244000169997 Schnittsellerie Species 0.000 description 1
- 208000034700 Vitreous opacities Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004430 ametropia Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007227 biological adhesion Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- -1 decoction Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 210000004561 lacrimal apparatus Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 230000004493 normal intraocular pressure Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The eyesight improving effect nano gasified glue for improving the eyesight of the myopia is prepared from stauntonvine polysaccharide, acoarine and the like, has stable drug effect, can adjust the intraocular pressure to restore normal, effectively relieves the myopia and cataract from no aggravation of eyesight, inhibits the eyeball lens protein from being denatured and turbid, can quickly recover, breaks through the situation that the nano gasified glue is not used for natural continuous gasification and administration at room temperature for hundreds of years, and can improve the number of people with half-grid unequal eyesight after the myopia, presbyopia and cataract are dripped, and the effective rate is 99%. The eye drops are applied to normal eyes more than six years old once a day, various eye diseases are efficiently prevented, the effective rate of eliminating fine lines and canthus wrinkles of eyelids is 100%, 100% of people can read books, computers, mobile phones, automobiles and the like immediately after the eyes are applied, and the eyes feel very bright and comfortable all day after the eyes are applied.
Description
Technical Field
The present invention belongs to the field of medicine technology. The invention particularly relates to a crystalline myopia eyesight improving effect nano gasified gum extracted from plants, and relates to an eyesight improving effect nano gasified gum for improving myopia and a preparation method thereof.
Background
The main symptoms of myopia are looking near to normal and looking far away with blurred objects. Myopia is a functional disorder of the eye, and under normal conditions, when the eye is relaxed to accommodate, external parallel light enters the eye, and the focus of the parallel light falls on the retina, so that a clear image is formed, which is called emmetropia. If the focus does not fall on the retina, it is called non-emmetropia, i.e. ametropia, and the focus falls in front of the retina, so that a clear image cannot be formed on the retina, i.e. a myopic eye. Except for poor far vision, the patients often have poor night vision, muscae volitantes, floaters, glittering sensation and the like, and after excessive eye use, the patients have double images, photophobia, dry eyes, itching eyes, foreign body sensation of eyes, soreness and swelling of eyes, headache and the like. Severe cases also cause retinal detachment, tears, macular hemorrhage, neovascularization, and open angle glaucoma. Thus, myopia has become a significant public health problem affecting juvenile eye health, and the world health organization is listed as one of three major diseases.
At present, the traditional Chinese medicine for internal treatment and external treatment for preventing and treating myopia mainly comprises oral liquid, decoction, granules, pills, granules, tablets, capsules, oral liquid for removing the obstacles, compound ginseng fruit liquid, decoction for promoting blood circulation and removing the obstacles, granules for eliminating the obstacles, granules for recovering the eyesight, pills for treating the obstacles No. 1, pills for removing nebula, tablets for recovering the eyesight, capsules for strengthening the foundation and improving the eyesight, pills for eliminating the obstacles, pills for improving the eyesight, golden flower pills for improving the eyesight, oral liquid for clearing the cataract, compound granules for improving the eyesight for treating the sugar obstacles, bear gall pills and the like. These drugs are poor or ineffective and have large side effects. The external treatment method mainly comprises powder, eye drops, eye ointment and eye patches. In addition, the eye drop can be used for treating diseases such as musczhu Mingmu powder, ZYM eye drop, BAILINGLING, eye lyophilized injection for eliminating cataract, eye drop for recovering eyesight, compound Hirudo eye drop, compound Chinese medicinal eye drop, QUYANLING eye drop, and YIXIANG eye drop. The medicine carrying amount of the local eye drops is small, and the eye drops are frequently used by patients; the local eye drops and the eye ointment have the advantages of too few effective factors, no slow-release gasification function, poorer biological adhesion, small dosage, short time of acting on eyes, too short retention time in the eyes, extremely quick elimination, poor or ineffective prevention and treatment effect, extremely difficult penetration of the local eye drops through the physiological structure of eyeballs to the back eye parts and certain toxic and side effect. At home and abroad, only one method for correcting the myopia by using the lens is popularized. The lens correction and the instrument do not directly administer medicine to the focus, thus the eye disease can not be fundamentally recovered, the eye disease can not be cured, and the eye disease is easy to relapse and aggravate. Above generally can not effectively alleviate asthenopia, and the effect of promoting eye vision is very limited, for example: the eyesight is difficult to be effectively improved after being improved to 0.6 or 0.7, the eyesight cannot be stabilized, and the effect of not aggravating the eyesight cannot be delayed.
In recent years, the nano gasified glue with the eyesight improving effect for improving the eyesight of the myopic eye at home and abroad is dripped on an eyelid to prevent and treat the myopic eye, natural and continuous gasification dosing is performed at room temperature, the transdermal blood circulation activating effect is rapid, the nano gasified glue is a very simple transdermal dosing mode, is widely concerned by researchers, many experts and scholars want to research, but no one-man research is successful, the nano gasified glue is unprecedented, registration, report and patent publication of eye diseases such as prevention and treatment of the myopic eye by dripping the nano gasified glue on the eyelid and eyelash penetration are not existed in the preparation pharmacopoeias at home and abroad at present, so the nano gasified glue with the eyesight improving effect for improving the eyesight of the myopic eye fills up the blank at home and abroad, and the research success of the nano gasified glue with the eyesight improving effect has great significance.
Disclosure of Invention
In order to solve the defects, the invention provides the eyesight improving effect nano gasified rubber for improving the eyesight of the myopia, which is characterized in that the eyesight improving effect nano gasified rubber is naturally and continuously gasified and administrated at room temperature, is adhered to the upper, lower, left, right and periphery of the eyelash and eyelid edge, gaseous molecules of the nano gasified rubber collide to the eyeball and tear gland tears to dissolve and wet the eyeball cornea, crystalline lens, ciliary body, retina and the like, wash and remove wastes, kill pathogenic bacteria and viruses, enter eyeball blood circulation by feet, adjust intraocular pressure, repair and regulate damaged cells of the eyeball, activate the function of resting cells of the eyeball, slowly and effectively prevent and treat the myopia, can heal the myopia at the early stage (more than 0.8), and can improve the semi-three-half vision (calculated by taking a visual acuity chart as a standard grid number after the nano gasified rubber is used for the myopia, presbyopia and cataract at the middle and later stages, clinical verification results of several 10 years prove that the nano gasified gum has obvious effect, has the effects of stabilizing eyesight, delaying non-aggravation of eyesight, quickly eliminating asthenopia, resisting aging of eyes, eliminating fine lines of eyelids and canthus wrinkles, has high cure rate, obvious prevention and treatment effect, no pain and irritation to eyes, no side effect, convenient use and exact curative effect, and is used for improving eyesight of myopia and the preparation method thereof. Has wide prospect.
The invention relates to a nano gasified rubber composition with eyesight improving effect for improving myopia, which is characterized by being prepared from the following raw materials in parts by weight: the paint comprises the following components in parts by weight: 60-80 parts of stauntonvine polysaccharide, 1-9 parts of aconine, 10-20 parts of natural borneol crystal, 5-10 parts of chitosan and 20-40 parts of rice wine.
The nanometer gasification rubber composition for improving the eyesight of the myopia, disclosed by the invention, has the following preferable mixture ratio:
65 parts of stauntonvine polysaccharide, 1 part of aconine, 10 parts of natural borneol crystal, 6 parts of chitosan and 35 parts of rice wine:
the invention relates to a nano gasified rubber with eyesight improving effect for improving myopia and a preparation method thereof, which is characterized by comprising the following steps:
1) pulverizing the above raw materials, and sieving with 80 mesh sieve;
2) weighing stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan raw materials in parts by weight, and uniformly mixing to obtain total mixed powder for later use;
3) mixing the above total mixed powders, adding rice wine, stirring, heating to dissolve, cooling to 60 deg.C, and bottling to obtain nanometer gasified rubber with eyesight improving effect.
The nano gasified rubber with the eyesight improving effect is also applied to various glasses lenses, and is dripped around the edges of the glasses lenses to prevent and treat eye diseases such as myopia and the like.
The application and dosage are as follows: the method comprises the steps of cleaning the periphery of eye eyelids with water, cleaning hands, drying the periphery of the eyelids and the hands, dripping 1 to three drops of the product on the heads of the hands, slightly closing two eyes, dripping the product on the upper, lower, left, right and periphery of eyelashes and the lower, left and right periphery of the eyelids, opening the eyes after coating, naturally drying the eye-improving effect nano gasified glue after 2 to 3 minutes, not rubbing the periphery of the eyelids after drying, dripping the product once after washing the face in the morning, dripping the product once after washing the face at night, and dripping the product once after dripping the eyes, so that the eyes feel very bright and comfortable all day after dripping the eyes.
The action principle of the nano gasification glue is as follows:
1. the solid state of the nano gasified colloid is directly changed into the gas state without passing through the phase change principle of the liquid state, and under the gas state of the nano gasified colloid, the gaseous molecules of the nano gasified glue have extremely high kinetic energy, the intermolecular force can not restrict the motion of the gaseous molecular nano-gas completely, the gaseous molecular nano-gas can reach any position at will, the gaseous molecules gasified by the nano gasified glue collide to reach the eyeball and dissolve with lacrimal gland tears, wet the eyeball, cornea, crystalline lens, ciliary body, retina and the like to take a bath to remove wastes, kill germs and viruses, promote the blood circulation of the eyeball and adjust the intraocular pressure, the eye drop repairing and regulating method has the advantages that damaged eye drop cells are repaired and regulated, the resting cell function of eye drops is activated, the number of normal eye drop cells is increased, the activity of the eye drop cells is improved, the quality of the eye drop cells is improved, pathological changes of the cells are prevented and delayed, and the normal physiological function of the eye drop cells is recovered, so that the effects of preventing and treating eye diseases are achieved.
Indications of symptoms
Treating primary myopia, treating dry eye, treating primary cataract, preventing myopia, preventing presbyopia, preventing cataract, preventing pinkeye, rapidly recovering normal vision for asthenopia and ocular pruritus, and improving sleep.
The invention has the beneficial effects that:
1. the nano gasified rubber with the eyesight improving effect can effectively relieve the serious breakthrough that the myopia vision is not aggravated any more, the cataract vision is not aggravated any more, the macular degeneration vision is not aggravated any more, the glaucoma vision is not aggravated any more, and the opacity caused by the degeneration of eyeball lens protein is inhibited.
2. The nano gasified gel for treating myopia with the eyesight improving effect solves the problems of natural continuous gasification administration, sufficient drug effect stability, intraocular pressure adjustment, normal intraocular pressure recovery, eye swelling and blurred vision relief, no pain, no stimulation, no side effect and special convenience in use.
3. The worldwide problem that the nano gasified rubber without the eyesight improving effect is naturally and continuously gasified for administration for thousands of years, and can be used for preventing and treating cataract and quickly recovering early cataract and presbyopia is solved.
4. The nano gasified glue with the eyesight improving effect can be used for treating myopia, presbyopia and cataract in the early stage, the eyesight can be removed after the nano gasified glue is dripped and coated for 1 to 16 months, the normal eyesight can be recovered by more than 99 percent, and the nano gasified glue has wide prospect.
5. The nanometer gasified rubber with the eyesight improving effect can be used for treating dry eyes, pinkeye and bacterial eye diseases after being dripped for 2 to 6 days, and the effective rate is 99 percent
6. The eye drops are applied to normal eyes over six years old once a day by using the nano gasified rubber with the eyesight improving effect, so that the eye drops have the effect of efficiently preventing various eye diseases, and the effective rate is 100 percent. The medicine is good enough for sleep, has special effect of eliminating fine lines of eyelids and canthus wrinkles, and has effective rate of 100 percent for removing canthus wrinkles.
7. After the nano gasified rubber with the eyesight improving effect is dripped on myopia, presbyopia and cataract for 5-10 minutes, the number of people with three different vision half-cells (calculated by using the visual chart as a standard cell number) can be improved, and the effective rate is newly created with 99.9 percent.
8. 100% people can read books, television, computers, mobile phones, automobiles and the like immediately after the nano gasified rubber with the eyesight improving effect is dripped, and the unexpected technical effect is newly found.
The specific implementation mode is as follows:
the present invention will be further described with reference to the following examples. These examples are not intended to limit the scope of the present invention in any way. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention, and that such changes and modifications may be made without departing from the spirit and scope of the invention.
Example 1:
in this embodiment, the nanometer gasified rubber composition for improving myopia comprises the following raw material medicines: 60 parts of stauntonvine polysaccharide, 3 parts of aconine, 20 parts of natural borneol crystal, 5 parts of chitosan and 29 parts of rice wine;
the preparation method of the composition comprises the following steps:
(1) drying stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan, crushing, and sieving by a 80-mesh sieve;
(2) selecting the raw material powder of stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan in selected parts by weight;
(3) mixing the above powders, adding rice wine, stirring, heating to dissolve, cooling to 60 deg.C, and bottling to obtain nanometer gasified rubber with eyesight improving effect.
The nano gasified rubber with the eyesight improving effect is also applied to various glasses lenses, and is dripped around the edges of the glasses lenses to prevent and treat eye diseases such as myopia and the like.
The application and dosage are as follows: the method comprises the steps of cleaning the periphery of eye eyelids with water, cleaning hands, drying the periphery of the eyelids and the hands, dripping 1 to three drops of the product on the heads of the hands, slightly closing two eyes, dripping the product on the upper, lower, left, right and periphery of eyelashes and the lower, left and right periphery of the eyelids, opening the eyes after coating, naturally drying the eye-improving effect nano gasified glue after 2 to 3 minutes, not rubbing the periphery of the eyelids after drying, dripping the product once after washing the face in the morning, dripping the product once after washing the face at night, and dripping the product once after dripping the eyes, so that the eyes feel very bright and comfortable all day after dripping the eyes.
Example 2:
the eyesight improving effect nanometer gasified rubber composition for improving myopia eyesight comprises the following raw material medicaments in part by weight: 60 parts of stauntonvine polysaccharide, 2 parts of aconine, 10 parts of natural borneol crystal, 7 parts of chitosan and 30 parts of rice wine;
the preparation method of the composition comprises the following steps:
(1) drying stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan, crushing, and sieving by a 80-mesh sieve;
(2) selecting the raw material powder of stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan in selected parts by weight;
(3) mixing the above powders, adding rice wine, stirring, heating to dissolve, cooling to 60 deg.C, and bottling to obtain nanometer gasified rubber with eyesight improving effect.
The nano gasified rubber with the eyesight improving effect is also applied to various glasses lenses, and is dripped around the edges of the glasses lenses to prevent and treat eye diseases such as myopia and the like.
Example 3:
the eyesight improving effect nanometer gasified rubber composition for improving myopia eyesight comprises the following raw material medicaments in part by weight: 70 parts of stauntonvine polysaccharide, 4 parts of aconine, 15 parts of natural borneol crystal, 8 parts of chitosan and 32 parts of rice wine;
the preparation method of the composition comprises the following steps:
(1) drying stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan, crushing, and sieving by a 80-mesh sieve;
(2) selecting the raw material powder of stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan in selected parts by weight;
(3) mixing the above powders, adding rice wine, stirring, heating to dissolve, cooling to 60 deg.C, and bottling to obtain nanometer gasified rubber with eyesight improving effect.
The nano gasified rubber with the eyesight improving effect is also applied to various glasses lenses, and is dripped around the edges of the glasses lenses to prevent and treat eye diseases such as myopia and the like.
Example 4:
the eyesight improving effect nanometer gasified rubber composition for improving myopia eyesight comprises the following raw material medicaments in part by weight: 80 parts of stauntonvine polysaccharide, 2 parts of aconine, 10 parts of natural borneol crystal, 5 parts of chitosan and 32 parts of rice wine;
the preparation method of the composition comprises the following steps:
(1) drying stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan, crushing, and sieving by a 80-mesh sieve;
(2) selecting the raw material powder of stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan in selected parts by weight;
(3) mixing the above powders, adding rice wine, stirring, heating to dissolve, cooling to 60 deg.C, and bottling to obtain nanometer gasified rubber with eyesight improving effect.
The nano gasified rubber with the eyesight improving effect is also applied to various glasses lenses, and is dripped around the edges of the glasses lenses to prevent and treat eye diseases such as myopia and the like.
Example 5:
the eyesight improving effect nanometer gasified rubber composition for improving myopia eyesight comprises the following raw material medicaments in part by weight: 80 parts of stauntonvine polysaccharide, 5 parts of aconine, 20 parts of natural borneol crystal, 10 parts of chitosan and 34 parts of rice wine;
the preparation method of the composition comprises the following steps:
(1) drying stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan, crushing, and sieving by a 80-mesh sieve;
(2) selecting the raw material powder of stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan in selected parts by weight;
(3) mixing the above powders, adding rice wine, stirring, heating to dissolve, cooling to 60 deg.C, and bottling to obtain nanometer gasified rubber with eyesight improving effect.
The nano gasified rubber with the eyesight improving effect is also applied to various glasses lenses, and is dripped around the edges of the glasses lenses to prevent and treat eye diseases such as myopia and the like.
Example 6:
the eyesight improving effect nanometer gasified rubber composition for improving myopia eyesight comprises the following raw material medicaments in part by weight: 80 parts of stauntonvine polysaccharide, 2 parts of aconine, 15 parts of natural borneol crystal, 15 parts of chitosan and 33 parts of rice wine;
the preparation method of the composition comprises the following steps:
(1) drying stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan, crushing, and sieving by a 80-mesh sieve;
(2) selecting the raw material powder of stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan in selected parts by weight;
(3) mixing the above powders, adding rice wine, stirring, heating to dissolve, cooling to 60 deg.C, and bottling to obtain nanometer gasified rubber with eyesight improving effect.
The nano gasified rubber with the eyesight improving effect is also applied to various glasses lenses, and is dripped around the edges of the glasses lenses to prevent and treat eye diseases such as myopia and the like.
Typical cases;
clinical statistics for 10 years:
example 1
The effective rate of the nanometer gasified rubber for treating myopia of 6-9 students with the eyesight improving effect is 99.9%, wherein the effective rate is 99.3%, and the myopia is completely cured by more than 0.7%;
example 2
The effective rate of the nanometer gasified rubber for treating the myopia of the pupils is 98.9 percent, wherein the significant efficiency is 93.1 percent, and the myopia is completely cured by more than 0.8 percent;
example 3
The effective rate of treating myopia of junior and middle school students by the nanometer gasified rubber with the eyesight improving effect is 99.7%, wherein the obvious effective rate is 94.3%, and the myopia is completely cured by more than 0.8%;
example 4
The effective rate of treating myopia of junior and middle school students by the nanometer gasified rubber with the eyesight improving effect is 99.9 percent, wherein the obvious effective rate is 99.6 percent, and the myopia is completely cured by more than 0.8 percent;
example 5
The effective rate of the nanometer gasified rubber for treating myopia of high school students is 100%, and myopia of over 0.7 is completely cured;
example 6
The effective rate of the nanometer gasified rubber for treating myopia of high school students with the eyesight improving effect is 99.6%, wherein the obvious effective rate is 99.5%, and the myopia is completely cured by more than 0.8%;
clinical summary shows that the eye disease is short due to small age, and the nano gasified gel has a particularly effective treatment effect through improving eyesight.
Typical cases;
1. when a certain Liu is in age of 7 years old and male, students have myopia at 0.8 degree, the eyesight improving effect is achieved by using the nano gasified rubber for 1 month, the eyesight is 1, the eye pain and dryness are eliminated, after two months of use, the myopia force is changed to 1.5, the glasses are taken off, the eyeballs become darker, and the disease does not relapse after two years of follow-up visit.
2. One of them, male, age 61. Cataract, blurred vision of left eye for more than 2 years, foreign body, dry pain, vision of left 0.8, vitreous opacity, visual acuity recovery to 1 after 50 days of using the eyesight improving effect nano gasified rubber, vision of left 1.0, continuous use for three months, turbid matter cure, fine lines of eyelid and canthus wrinkles removal, and no recurrence after four years.
3. Certain Liu is female, age 39, eyes are dry and acerb, the eyes are afraid of light and pain, the eyesight improving effect is achieved by using the nano gasified rubber for 15 days to cure, the vision is stable, fine lines of eyelids and wrinkles of canthus are removed, a patient feels comfortable when using the nano gasified rubber, and the patient is still using the nano gasified rubber.
4, certain blue, male, age 70, presbyopia, lenticular opacity, cataract, unclear seeing the 3 rd word, usually feel foreign body in eyes, check vision 0.5, use improve eyesight effect nanometer gasification glue 280 days, binocular vision 0.9, no recurrence in present 3 years.
5. When a man is aged 58 years old and often watches a mobile phone and plays a computer, the eye fatigue is seriously damaged, the visual power is 0.5, and after 90 days of using the eyesight improving effect nano gasified rubber, the visual power is improved by 1.0, the fatigue is eliminated, and the vision is recovered to be normal.
The foregoing is only a preferred embodiment of this invention and it should be noted that modifications can be made by those skilled in the art without departing from the principle of the invention and these modifications are to be considered as the scope of the invention.
Claims (1)
1. An eyesight-improving nano gasified rubber composition for improving myopia and eyesight, which is characterized by being prepared from the following raw materials in parts by weight: the paint comprises the following components in parts by weight: 60-80 parts of stauntonvine polysaccharide, 1-9 parts of aconine, 10-20 parts of natural borneol crystal, 5-10 parts of chitosan and 20-40 parts of rice wine; the above composition is prepared by the following method; 60 parts of stauntonvine polysaccharide, 3 parts of aconine, 20 parts of natural borneol crystal, 5 parts of chitosan and 29 parts of rice wine; the preparation method of the composition comprises the following steps:
(1) pulverizing the above raw materials, and sieving with 80 mesh sieve;
(2) weighing stauntonvine polysaccharide, aconine, natural borneol crystal and chitosan raw materials in parts by weight, and uniformly mixing to obtain total mixed powder for later use;
(3) mixing the above total mixed powder, adding rice wine, stirring, heating for dissolving, cooling to 60 deg.C, and bottling to obtain nanometer gasified glue with eyesight improving effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111427174.2A CN114053296A (en) | 2021-11-28 | 2021-11-28 | Eyesight improving nano gasified rubber for myopia and its prepn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111427174.2A CN114053296A (en) | 2021-11-28 | 2021-11-28 | Eyesight improving nano gasified rubber for myopia and its prepn |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114053296A true CN114053296A (en) | 2022-02-18 |
Family
ID=80276833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111427174.2A Pending CN114053296A (en) | 2021-11-28 | 2021-11-28 | Eyesight improving nano gasified rubber for myopia and its prepn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114053296A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016164202A (en) * | 2011-08-18 | 2016-09-08 | ジョンナム バイオインダストリー ファウンデーション | Medical composition containing stauntonia hexaphylla extract |
| CN108578523A (en) * | 2018-06-19 | 2018-09-28 | 赣州安宏环保科技有限公司 | Prevent the gasification infiltration fat glasses and preparation method thereof of macular degeneration cataract myopia |
| CN110123758A (en) * | 2019-07-01 | 2019-08-16 | 北京元莱健康管理有限公司 | A kind of eye sprays agent, preparation method and application method with alleviation visual fatigue, improvement dry eye condition |
-
2021
- 2021-11-28 CN CN202111427174.2A patent/CN114053296A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016164202A (en) * | 2011-08-18 | 2016-09-08 | ジョンナム バイオインダストリー ファウンデーション | Medical composition containing stauntonia hexaphylla extract |
| CN108578523A (en) * | 2018-06-19 | 2018-09-28 | 赣州安宏环保科技有限公司 | Prevent the gasification infiltration fat glasses and preparation method thereof of macular degeneration cataract myopia |
| CN110123758A (en) * | 2019-07-01 | 2019-08-16 | 北京元莱健康管理有限公司 | A kind of eye sprays agent, preparation method and application method with alleviation visual fatigue, improvement dry eye condition |
Non-Patent Citations (1)
| Title |
|---|
| 钟赣生: "《中药学》", 31 August 2016, 中国中医药出版社, pages: 363 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109091675B (en) | Compound low-concentration atropine medicine eye drops and preparation method thereof | |
| CN110170000A (en) | A kind of Chinese medicine composition and preparation method thereof for helping to improve eyesight | |
| CN100546609C (en) | The application of a kind of compositions in the cataractous medicine of preparation control | |
| CN102188604A (en) | Medicament for treating myopia and presbyopia | |
| CN104225265A (en) | Traditional Chinese medicine composition for alleviating asthenopia | |
| CN1824056B (en) | Applicaiton of a Chinese-western medicine combined composition for preparing medicine and food dual purpose nutritive product for preventing and treating cataract | |
| CN1824045A (en) | Medicine and food dual purpose nutritive product for preventing and treating cornea malacia and its manufacturing method | |
| CN100384453C (en) | Medicine and food dual purpose nutritive product for preventing and treating synchysis and its manufacturing method | |
| CN1824050B (en) | Applicaiton of a composition for preparing medicine and food dual purpose nutritive product for preventing and treating xeroma | |
| CN100536879C (en) | Application for combination for preparing food dual purpose nutritive product for preventing and treating cataract | |
| CN1824049A (en) | Medicine and food dual purpose Chinese and western medicinal nutritive product for preventing and treating xeroma and its manufacturing method | |
| CN1824059B (en) | Use of nutritive product for preventing and treating nightblindness | |
| CN100384456C (en) | Medicine and food dual purpose product for preventing pseudomyopia and true myopia and its manufacturing method | |
| CN100546610C (en) | Pre-myopia prevention medicine-food two-purpose product and manufacture method | |
| CN1824061B (en) | Application of a combination for preparing medicine and food dual purpose nutrient for preventing true myopia | |
| CN1824047A (en) | Chinese medicine and food dual purpose nutritive product for preventing and treating cornea malacia and its manufacturing method | |
| CN1824025B (en) | Applicaiton of a Chinese-western medicine combined composition for preparing medicine and frod dual purpose nutrient for preventing frue myopia | |
| CN1824063A (en) | Medicine and food dual purpose Chinese and western medicine combined product for preventing and trecting pseudomyopia and its manufacturing method | |
| CN1824057B (en) | Use of Chinese and western medicine combined composition for preparing product with edible and medicine function for treating nightblindness | |
| CN1824052B (en) | Use of composition in preparing product for preventing pseudomyopia and true myopia | |
| CN1824064B (en) | Use of composition in preparing nutrients with edible and medicinal function for treating pseudomyopia | |
| CN100536880C (en) | Application for combination for preparing food dual purpose Chinese and western medicine combined product for preventing myopia | |
| CN110652390A (en) | Eye shield with effect of improving eyesight for myopia and presbyopia and preparation method thereof | |
| CN114053296A (en) | Eyesight improving nano gasified rubber for myopia and its prepn | |
| CN211095171U (en) | Eye-shade with effect of improving eyesight for myopia and presbyopia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |